World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
153
Citations
79249
World Ranking
1052
National Ranking
604

Steven M. Larson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Steven M. Larson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 934 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Steven M. Larson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Steven M. Larson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 153 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2005 - Member of the National Academy of Medicine (NAM)

Overview

Steven M. Larson is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their work spans a broad range of topics within the field of medicine, with a focus on radiology, nuclear medicine, and imaging. Most of their research is concentrated in the subfields of radiology, nuclear medicine, pulmonary and respiratory medicine, molecular biology, oncology, and genetics.

The main topics covered in their work include:

  • Radiopharmaceutical Chemistry and Applications
  • Medical Imaging Techniques and Applications
  • Prostate Cancer Treatment and Research
  • Monoclonal and Polyclonal Antibodies Research
  • Intraperitoneal and Appendiceal Malignancies
  • Neuroblastoma Research and Treatments
  • Thyroid Cancer Diagnosis and Treatment

Steven M. Larson has frequently collaborated with several coauthors, including:

  • Darren R. Veach
  • Nai-Kong V. Cheung
  • Sarah M. Cheal
  • Pat Zanzonico
  • Hong-Fen Guo

Their most common publication venues include:

  • Journal of Nuclear Medicine
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • European Journal of Nuclear Medicine and Molecular Imaging
  • Theranostics

Recent papers authored or coauthored by Steven M. Larson illustrate their research interests and recent contributions:

  • "Pretargeting: A Path Forward for Radioimmunotherapy," 2022, Journal of Nuclear Medicine
  • "Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies," 2022, Journal of Hematology & Oncology
  • "Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer," 2020, JCO Precision Oncology
  • "2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer," 2025, Thyroid
  • "A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals," 2021, European Journal of Nuclear Medicine and Molecular Imaging

Steven M. Larson has been recognized as a member of the National Academy of Medicine since 2005.

Best Publications

  • The pharmacology of monoclonal antibodies.

    John N Weinstein;R. R. Eger;D. G. Covell;C. D.V. Black

  • Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality.

    C.Clifton Ling;John Humm;Steven Larson;Howard Amols

  • Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.

    Howard I Scher;Tomasz M Beer;Celestia S Higano;Aseem Anand

  • Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

    Renier J. Brentjens;Jean Baptiste Latouche;Elmer Santos;Francesc Marti

  • Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

    Alan L. Ho;Ravinder K. Grewal;Rebecca Leboeuf;Eric J. Sherman

  • Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

    Gary J. Kelloff;John M. Hoffman;Bruce Johnson;Howard I. Scher

  • Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials

    Lalitha K. Shankar;John M. Hoffman;Steve Bacharach;Michael M. Graham

  • Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

    Daniel C. Danila;Glenn Heller;Gretchen A. Gignac;Rita Gonzalez-Espinoza

  • Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

    Steven M. Larson;Yusuf Erdi;Timothy Akhurst;Madhu Mazumdar

  • Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe

    Evan Phillips;Oula Penate-Medina;Pat B. Zanzonico;Richard D. Carvajal

  • Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma

    Miriam Benezra;Oula Penate-Medina;Pat B. Zanzonico;David Schaer

  • Positron emission tomography in Alzheimer's disease

    Ranjan Duara;Cheryl L. Grady;James V. Haxby;M. Sundaram

  • Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts

    Renier J. Brentjens;Elmer Santos;Yan Nikhamin;Raymond Yeh

  • Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning

    Richard J. Robbins;Qiang Wan;Ravinder K. Grewal;Roland Reibke

  • Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding.

    Yusuf E. Erdi;O. Mawlawi;Steven M. Larson;M. Imbriaco

  • Targeted α particle immunotherapy for myeloid leukemia

    Joseph G. Jurcic;Steven M. Larson;Steven M. Larson;George Sgouros;George Sgouros;Michael R. McDevitt;Michael R. McDevitt

  • A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

    Andrew M Scott;Greg Wiseman;Sydney Welt;Alex Adjei

  • Radioimmunotherapy with alpha-emitting nuclides

    Michael R. McDevitt;George Sgouros;Ronald D. Finn;John L. Humm

  • Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer

    Daniel C. Danila;Michael J. Morris;Johann S. De Bono;Charles J. Ryan

  • Prediction of survival in glioma patients by means of positron emission tomography

    N.J. Patronas;G. Di Chiro;C. Kufta;D. Bairamian

Frequent Co-Authors

John L. Humm
John L. Humm Memorial Sloan Kettering Cancer Center
Jorge A. Carrasquillo
Jorge A. Carrasquillo Memorial Sloan Kettering Cancer Center
Michael J. Morris
Michael J. Morris Memorial Sloan Kettering Cancer Center
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Heiko Schöder
Heiko Schöder Memorial Sloan Kettering Cancer Center
Nai-Kong V. Cheung
Nai-Kong V. Cheung Memorial Sloan Kettering Cancer Center
Mithat Gonen
Mithat Gonen Memorial Sloan Kettering Cancer Center
Jason S. Lewis
Jason S. Lewis Memorial Sloan Kettering Cancer Center
Homer A. Macapinlac
Homer A. Macapinlac The University of Texas MD Anderson Cancer Center
Andrew M. Scott
Andrew M. Scott La Trobe University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is a highly competitive field, but there are related online degrees and fulfilling career pathways available for students seeking flexible options. For those without a nursing background, direct entry msn programs for non-nursing majors online offer an accelerated route into advanced nursing by allowing you to earn a master’s degree directly, even if your bachelor’s isn’t in nursing.

If you are concerned about admission difficulty, exploring what is the easiest nursing program to get into may help you identify institutions with higher acceptance rates or more flexible prerequisites.

Not all healthcare careers require a clinical background. For example, medical billing and coding is a strong alternative with many certified programs available online. Look for online medical billing and coding schools that accept fafsa if you need financial support.

Furthermore, some nursing schools have moved away from traditional entrance exams. If testing is a concern, consider a nursing school without teas test requirements, making the application process a bit simpler.

Best Scientists Citing Steven M. Larson

Trending Scientists

Recently Published Articles